NO20003845L - Behandling av kvinnelig seksuell dysfunksjon - Google Patents

Behandling av kvinnelig seksuell dysfunksjon

Info

Publication number
NO20003845L
NO20003845L NO20003845A NO20003845A NO20003845L NO 20003845 L NO20003845 L NO 20003845L NO 20003845 A NO20003845 A NO 20003845A NO 20003845 A NO20003845 A NO 20003845A NO 20003845 L NO20003845 L NO 20003845L
Authority
NO
Norway
Prior art keywords
treatment
sexual dysfunction
female sexual
female
dysfunction
Prior art date
Application number
NO20003845A
Other languages
English (en)
Other versions
NO319821B1 (no
NO20003845D0 (no
Inventor
Ragab El-Rashidy
Bruce Ronsen
Original Assignee
Pentech Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pentech Pharmaceuticals Inc filed Critical Pentech Pharmaceuticals Inc
Publication of NO20003845D0 publication Critical patent/NO20003845D0/no
Publication of NO20003845L publication Critical patent/NO20003845L/no
Publication of NO319821B1 publication Critical patent/NO319821B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
NO20003845A 1998-01-30 2000-07-27 Doseringsformer av apomorfin som er nyttige for forbedring av kvinnelig seksuell dysfunksjon NO319821B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/016,252 US5945117A (en) 1998-01-30 1998-01-30 Treatment of female sexual dysfunction
PCT/US1999/001776 WO1999038467A1 (en) 1998-01-30 1999-01-28 Treatment of female sexual dysfunction

Publications (3)

Publication Number Publication Date
NO20003845D0 NO20003845D0 (no) 2000-07-27
NO20003845L true NO20003845L (no) 2000-09-28
NO319821B1 NO319821B1 (no) 2005-09-19

Family

ID=21776169

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003845A NO319821B1 (no) 1998-01-30 2000-07-27 Doseringsformer av apomorfin som er nyttige for forbedring av kvinnelig seksuell dysfunksjon

Country Status (34)

Country Link
US (2) US5945117A (no)
EP (1) EP1056419A4 (no)
JP (1) JP2002501875A (no)
KR (1) KR20010040477A (no)
CN (1) CN1250221C (no)
AR (1) AR017976A1 (no)
AU (1) AU752928B2 (no)
BG (1) BG64667B1 (no)
BR (1) BR9908038A (no)
CA (1) CA2322289A1 (no)
CO (1) CO4970819A1 (no)
CR (1) CR5959A (no)
DZ (1) DZ2714A1 (no)
GC (1) GC0000096A (no)
GT (1) GT199900013A (no)
HK (1) HK1040901B (no)
HN (1) HN1999000015A (no)
HU (1) HUP0101268A3 (no)
IL (2) IL137569A0 (no)
JO (1) JO2085B1 (no)
MA (1) MA26600A1 (no)
MX (1) MXPA00007447A (no)
NO (1) NO319821B1 (no)
NZ (1) NZ506597A (no)
PA (1) PA8467801A1 (no)
PE (1) PE20000240A1 (no)
PL (1) PL194350B1 (no)
SK (1) SK11362000A3 (no)
TN (1) TNSN99008A1 (no)
TR (1) TR200002220T2 (no)
TW (1) TW550069B (no)
UY (1) UY25374A1 (no)
WO (1) WO1999038467A1 (no)
ZA (1) ZA99686B (no)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020165122A1 (en) * 1994-04-22 2002-11-07 Heaton Jeremy P. W. Method and compositions for the treatment or amelioration of female sexual dysfunction
US6395744B1 (en) * 1994-04-22 2002-05-28 Queen's University At Kingston Method and compositions for the treatment or amelioration of female sexual dysfunction
US20050065161A1 (en) * 1996-02-02 2005-03-24 Nitromed, Inc. Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
US6472425B1 (en) 1997-10-31 2002-10-29 Nitromed, Inc. Methods for treating female sexual dysfunctions
US5945117A (en) * 1998-01-30 1999-08-31 Pentech Pharmaceuticals, Inc. Treatment of female sexual dysfunction
AU2003204720B2 (en) * 1998-05-29 2006-06-29 Tap Pharmaceutical Products Inc. Methods for the normalization of sexual response and amelioration of long term genital tissue degradation
WO1999066909A2 (en) * 1998-06-22 1999-12-29 Univ Kingston Method and compositions for the treatment or amelioration of female sexual dysfunction
US20050245494A1 (en) * 1999-07-01 2005-11-03 40 J's Llc Methods to treat one or all of the defined etiologies of female sexual dysfunction
US20040254153A1 (en) * 1999-11-08 2004-12-16 Pfizer Inc Compounds for the treatment of female sexual dysfunction
BR0005797A (pt) * 2000-03-20 2001-10-16 Abbott Lab Métodos para o tratamento de disfunção sexual com apomorfina em nìveis de concentração plasmática especificados
CZ20023637A3 (cs) 2000-04-07 2003-02-12 Tap Pharmaceutical Products, Inc. Deriváty apomorfinu a způsoby jejich použití
CA2408399A1 (en) * 2000-05-09 2001-11-15 Nitromed, Inc. Infrared thermography and methods of use
AU2001273636A1 (en) 2000-06-27 2002-01-08 Qualilife Pharmaceuticals Inc. Compositions and methods for treating females sexual response
US7223406B2 (en) * 2000-07-21 2007-05-29 The Regents Of The University Of California Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
WO2002007757A2 (en) 2000-07-21 2002-01-31 Lue Tom F Prevention and treatment of sexual arousal disorders
US20020065286A1 (en) * 2000-08-21 2002-05-30 Davies Michael John Treatment of wounds
US6528521B2 (en) 2000-11-15 2003-03-04 Tap Pharmaceutical Products, Inc. Treatment of anti-depression drug-induced sexual dysfunction with apomorphine
ATE358483T1 (de) * 2000-11-22 2007-04-15 Abbott Lab Selektive dopamin-d4-rezeptoragonisten zur behandlung von sexuellen dysfunktionen
WO2002062315A1 (en) * 2001-02-08 2002-08-15 Pharmacia Corporation Rapid-onset medicament for the treatment of sexual dysfunction
AU2003223304A1 (en) * 2002-03-19 2003-10-08 Michael Holick Glycoside and orthoester glycoside derivatives of apomorphine, analogs, and uses thereof
US20030219696A1 (en) * 2002-05-23 2003-11-27 Moreland Gerald W. Method and apparatus for preventing backflow in dental saliva evacuators
GB0219961D0 (en) 2002-08-28 2002-10-02 Pfizer Ltd Oxytocin inhibitors
GB0221711D0 (en) * 2002-09-19 2002-10-30 Ardana Bioscience Ltd Methods
CA2445212A1 (en) * 2002-10-10 2004-04-10 Queen's University At Kingston Treatment of sexual dysfunction
CA2451267A1 (en) * 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
US20040204439A1 (en) * 2003-04-14 2004-10-14 Staniforth John Nicholas Composition, device, and method for treating sexual dysfunction via inhalation
BRPI0409380A (pt) * 2003-04-14 2006-04-18 Vectura Ltd composições farmacêuticas
US7276246B2 (en) * 2003-05-09 2007-10-02 Cephalon, Inc. Dissolvable backing layer for use with a transmucosal delivery device
US7306812B2 (en) 2003-05-09 2007-12-11 Cephalon, Inc. Dissolvable backing layer for use with a transmucosal delivery device
GB0314054D0 (en) * 2003-06-17 2003-07-23 Pfizer Ltd Amide derivatives as selective serotonin re-uptake inhibitors
US20050054688A1 (en) * 2003-08-08 2005-03-10 Pfizer Inc Selective serotonin reuptake inhibitors in the treatment of disease
DE10338174A1 (de) * 2003-08-20 2005-03-24 Lts Lohmann Therapie-Systeme Ag Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit
US7291640B2 (en) * 2003-09-22 2007-11-06 Pfizer Inc. Substituted triazole derivatives as oxytocin antagonists
GB0409744D0 (en) * 2004-04-30 2004-06-09 Pfizer Ltd Novel compounds
WO2005105763A1 (en) * 2004-04-30 2005-11-10 Warner-Lambert Company Llc Substituted morpholine compounds for the treatment of central nervous system disorders
EP1863484A1 (en) * 2005-03-21 2007-12-12 Pfizer Limited Substituted triazole derivatives as oxytocin antagonists
ATE412648T1 (de) * 2005-03-21 2008-11-15 Pfizer Ltd Substituierte triazolderivate als oxytocinantagonisten
JP5256425B2 (ja) * 2005-04-08 2013-08-07 リングアル コンセグナ ピーティーワイ エルティーディー 口腔送達システム
US20100222365A1 (en) * 2005-08-10 2010-09-02 Pfizer Inc Substituted triazole deriviatives as oxytocin antagonists
CA2914168C (en) 2006-03-28 2018-05-08 Atir Holding S.A. Pyrido[1,2-a]pyrimidin-4-one derivatives and their use in the treatment of sexual disorders
US7800094B2 (en) * 2007-06-11 2010-09-21 Macronix International Co., Ltd. Resistance memory with tungsten compound and manufacturing
EP2442650B1 (en) 2009-06-12 2015-08-26 Cynapsus Therapeutics Inc. Sublingual apomorphine
WO2011130608A1 (en) * 2010-04-15 2011-10-20 Life Science Enhancement Corporation Methods and compositions for enhancing female sexual arousal and treating female sexual dysfunction
AU2011343429B2 (en) 2010-12-16 2016-10-20 Sunovion Pharmaceuticals Inc. Sublingual films
EP3581567A1 (en) 2011-04-10 2019-12-18 Atir Holding S.A. Heterocyclic compounds and uses thereof in the treatment of sexual disorders
EP2545905A1 (en) 2011-07-11 2013-01-16 Britannia Pharmaceuticals Limited A new therapeutical composition containing apomorphine as active ingredient
WO2016172095A1 (en) 2015-04-21 2016-10-27 Cynapsus Therapeutics, Inc. Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4521421A (en) * 1983-09-26 1985-06-04 Eli Lilly And Company Treatment of sexual dysfunction
WO1993023035A2 (en) * 1992-05-18 1993-11-25 Smithkline Beecham Plc Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and parkinson's disease
US5565466A (en) * 1993-08-13 1996-10-15 Zonagen, Inc. Methods for modulating the human sexual response
DE69514794T2 (de) * 1994-04-22 2000-07-27 Pentech Pharmaceuticals Inc Sublinguale dosierungsformen enthaltend apomorphin zur verwendung bei der behandlung von erektiler dysfunktion
US5562917A (en) * 1994-12-23 1996-10-08 Pentech Pharmaceuticals, Inc. Transdermal administration of apomorphine
US5624677A (en) * 1995-06-13 1997-04-29 Pentech Pharmaceuticals, Inc. Controlled release of drugs delivered by sublingual or buccal administration
US5945117A (en) * 1998-01-30 1999-08-31 Pentech Pharmaceuticals, Inc. Treatment of female sexual dysfunction

Also Published As

Publication number Publication date
PE20000240A1 (es) 2000-03-31
TNSN99008A1 (fr) 2005-11-10
BG64667B1 (bg) 2005-11-30
GT199900013A (es) 2001-07-20
NO319821B1 (no) 2005-09-19
IL137569A (en) 2006-08-01
SK11362000A3 (sk) 2001-02-12
MA26600A1 (fr) 2004-12-20
EP1056419A1 (en) 2000-12-06
BG104715A (bg) 2001-02-28
AU2564499A (en) 1999-08-16
TR200002220T2 (tr) 2000-12-21
NZ506597A (en) 2003-07-25
IL137569A0 (en) 2001-07-24
HUP0101268A2 (hu) 2001-09-28
CN1313742A (zh) 2001-09-19
JO2085B1 (en) 2000-05-21
CN1250221C (zh) 2006-04-12
DZ2714A1 (fr) 2003-09-01
GC0000096A (en) 2005-06-29
NO20003845D0 (no) 2000-07-27
HN1999000015A (es) 1999-08-23
PA8467801A1 (es) 2000-09-29
AU752928B2 (en) 2002-10-03
US6193992B1 (en) 2001-02-27
ZA99686B (en) 1999-07-28
AR017976A1 (es) 2001-10-24
HK1040901B (zh) 2006-11-24
PL342062A1 (en) 2001-05-21
HUP0101268A3 (en) 2002-12-28
KR20010040477A (ko) 2001-05-15
BR9908038A (pt) 2002-01-02
MXPA00007447A (es) 2006-01-25
EP1056419A4 (en) 2007-05-02
CA2322289A1 (en) 1999-08-05
PL194350B1 (pl) 2007-05-31
UY25374A1 (es) 1999-09-27
CO4970819A1 (es) 2000-11-07
HK1040901A1 (en) 2002-06-28
US5945117A (en) 1999-08-31
JP2002501875A (ja) 2002-01-22
TW550069B (en) 2003-09-01
WO1999038467A1 (en) 1999-08-05
CR5959A (es) 1999-07-28

Similar Documents

Publication Publication Date Title
NO20003845D0 (no) Behandling av kvinnelig seksuell dysfunksjon
EP1027057A4 (en) TREATMENT OF FEMALE SEXUAL DISORDERS
IL153492A0 (en) Treatment of male sexual dysfunction
IS2494B (is) Notkun á morfólínóli til meðhöndlunar á kynferðislegri vanvirkni
NO20005255D0 (no) Pyrazolpyrimidin-CGMPPDE5-inhibitorer for behandling av seksuell dysfunksjon
ATE269866T1 (de) Intranasale zubereitungen zur behandlung sexueller störungen
GB0225908D0 (en) Treatment of female sexual dysfunction
NO20024442L (no) Behandling av seksuell dysfunksjon med apomorfin
NO20030978D0 (no) Behandling av diuresedysfunksjon
EP1079764A4 (en) TREATMENT OF SEXUALITY DISORDERS IN CERTAIN GROUPS OF PATIENTS
DE50009813D1 (de) Kombinationpräparat zur behandlung von sexueller dysfunktion
PL362980A1 (en) Treatment of sexual dysfunction
IL155775A0 (en) Treatment of male sexual dysfunction
GB2386555B (en) Treatment of female sexual dysfunction
GB0011926D0 (en) Treatment of sexual dysfunction
GB0030647D0 (en) Treatment of male sexual dysfunction
NO942963D0 (no) Behandling av erektil dysfunksjon
SI1047428T1 (sl) Uporaba morfolinola za zdravljenje seksualne disfunkcije
GB0120679D0 (en) Treatment of male sexual dysfunction
GB0108730D0 (en) Treatment of male sexual dysfunction
GB0108483D0 (en) Treatment of male sexual dysfunction
GB0106167D0 (en) Treatment of male sexual dysfunction
GB0126904D0 (en) Treatment of sexual dysfunction
GB0111037D0 (en) Treatment of sexual dysfunction
GB0109910D0 (en) Treatment of sexual dysfunction